MoneyWorks4Me

The revenue for the March 2024 quarter is pegged at Rs. 2199.38 millions, about 18.00% up against Rs. 1863.84 millions recorded during the year-ago period.Profit saw a slight increase of 18.12%to Rs. 320.80  millions from Rs. 271.58 millions.Operating Profit saw a handsome growth to 487.07 millions from 406.44 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2199.38 1863.84 18.00 6875.83 6167.34 11.49 6875.83 6167.34 11.49
Other Income 85.54 -1.74 -5016.09 137.86 43.20 219.12 137.86 43.20 219.12
PBIDT 487.07 406.44 19.84 1214.53 1269.82 -4.35 1214.53 1269.82 -4.35
Interest 20.56 5.94 246.13 58.94 24.14 144.16 58.94 24.14 144.16
PBDT 466.51 400.50 16.48 838.05 1245.68 -32.72 838.05 1245.68 -32.72
Depreciation 43.63 34.27 27.31 146.94 123.42 19.06 146.94 123.42 19.06
PBT 422.88 366.23 15.47 691.11 1122.26 -38.42 691.11 1122.26 -38.42
TAX 102.08 94.65 7.85 254.25 288.82 -11.97 254.25 288.82 -11.97
Deferred Tax 29.02 5.96 386.91 45.12 25.05 80.12 45.12 25.05 80.12
PAT 320.80 271.58 18.12 436.86 833.44 -47.58 436.86 833.44 -47.58
Equity 368.81 364.37 1.22 368.81 364.37 1.22 368.81 364.37 1.22
PBIDTM(%) 22.15 21.81 1.56 17.66 20.59 -14.21 17.66 20.59 -14.21
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..